Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

Actuate Therapeutics(ACTU.US)

Event Tracking

Jan15

Craig-Hallum Maintains Buy Rating on Actuate Therapeutics

14:56

Nov14

Craig-Hallum Analyst Reiterates Buy Rating on Actuate Therapeutics

14:47

Actuate Therapeutics released FY2025 9 Months Earnings on November 13 (EST), with actual revenue of USD 0 and EPS of USD -0.8795

04:00

Actuate Therapeutics released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2527 (forecast USD --)

04:00

Aug15

Actuate Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3028 (forecast USD --)

03:00

Actuate Therapeutics released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -0.6267

03:00

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.407 M, EPS -0.2527

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.949 M, EPS -0.3028

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -6.317 M, EPS -0.3239

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

Actuate Therapeutics(ACTU.US)

Actuate Therapeutics Stock Performance Chart